The most common disorders of the ovaries are benign ovarian tumors which occur with an 80% incidence in women compared to malignancies. The incidence of benign ovarian tumors with cystic type in Indonesia in 2015 occurred as many as 23,400 people with a death rate of 13,800 people. In connection with this incident, there are several risk factors associated and the symptoms that occur are usually common such as gastrointestinal symptoms, urinary frequency, and constituent symptoms so that a proper diagnosis is needed by doing anamnesis, physical examination and supporting examinations. Supporting examinations can be done by ultrasound, MRI, X-rays and blood tests with tumor markers CA-125 where in malignant ovarian tumors, the tumor marker CA-125 increases, which is >35 IU/ml. Management of benign ovarian tumors is generally done through observation and also surgery depending on the degree of severity. The surgery that is usually performed is either partial surgery or radical surgery. Surgery is indicated if there are several indications such as cystic ovarian structures measuring more than 5 cm that have been observed for 6 - 8 weeks without regression, solid ovarian lesions, ovarian lesions with papillary vegetation on the cyst wall, and other indications as well.
Bamba K, Watanabe T, Kohno T. Anesthetic management of a patient with a giant ovarian tumor containing 83 l of fluid. Springerplus. 2013; 2: 487.
Cai S, Dai R, Mi J, Wang S, Jiang Y. Perioperative management of a patient with a giant ovarian tumor: A case report. Medicine (Baltimore). 2020; 99(41): e22625.
Zhang H, Yang Y, Wang Y, et al. Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification. J Ovarian Res. 2015; 8: 19.
Norell CH, Butler J, Farrell R, et al. Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care. Int J Gynecol Cancer. 2020; 30(11): 1748-1756.
Rady I, Bloch MB, Chamcheu RN, et al. Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxid Med Cell Longev. 2018; 2018: 1826170
Muhabat Q, Waheed F, Jabeen N. Clinical Presentation of Ovarian Tumors. Open Journal of Obstetrics and Gynecology. 2016; 06(04): 205-209.
Doubeni CA, Doubeni AR, Myers AE. Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016; 93(11): 937-944.
Sharadha S, Sridevi TA, Renukadevi TK, Gowri R, Binayak D, Indra V. Ovarian masses: changing clinico histopathological trends. J Obstet Gynaecol India. 2015; 65(1): 34-38.
Hashmi AA, Naz S, Edhi MM, Faridi N, Hussain SD, Mumtaz S, et al. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience. World J Surg Oncol. 2016; 14: 91.
Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016; 2: 16061.
Lu Y, Yao DS, Xu JH. Systematic review of laparoscopic comprehensive staging surgery in early stage ovarian cancer: a meta-analysis. Taiwan J Obstet Gynecol. 2015; 54(1): 29-38.
Trillsch F, Woelber L, Eulenburg C, et al. Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium. J Ovarian Res. 2013; 6(1): 42.
Zhang Y, Fan S, Xiang Y, Duan H, Sun L. Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: a meta-analysis of clinical studies. BMC Cancer. 2015; 15: 597.
Lee M, Kim SW, Paek J, et al. Comparisons of surgical outcomes, complications, and costs between laparotomy and laparoscopy in early-stage ovarian cancer. Int J Gynecol Cancer. 2011; 21(2): 251-256.
This work is licensed under a Creative Commons Attribution 4.0 International License.